Catalyst Wire Dossier Catalyst Wire Dossier

IPX066

carbidopa-levodopa formulation · Impax Laboratories, LLC
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for IPX066, covering 2016-01-14 to 2017-09-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066 [Phase 3]

See pricing